Form 4: Integrated BioPharma Director William Milmoe Acquires 50,000 Stock Options

Sentiment:

SEC Form 4


Director William Milmoe acquired 50,000 stock options in Integrated BioPharma Inc. on August 7, 2024.

Summary

  • On August 7, 2024, William H. Milmoe, a director and 10% owner of Integrated BioPharma Inc. (INBP), acquired 50,000 stock options.
  • The options have an exercise price of $0.20.
  • The stock options vest in four equal installments on September 30, 2024, December 31, 2024, March 31, 2025, and June 30, 2025.
  • The expiration date for the options is August 7, 2034.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports the acquisition of stock options by a director. It doesn't inherently indicate positive or negative prospects for the company.

Positives

  • A director's acquisition of stock options may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in the biopharmaceutical industry.

Stakeholder Impact

  • The acquisition of stock options by a director could be viewed positively by shareholders, potentially signaling confidence in the company's future.

Key Dates

DateDescription
08/07/2024Date of transaction: William Milmoe acquired 50,000 stock options.
08/07/2024Date of grant: Stock options granted.
09/30/2024First vesting date: 12,500 stock options vest.
12/31/2024Second vesting date: 12,500 stock options vest.
03/31/2025Third vesting date: 12,500 stock options vest.
06/30/2025Fourth vesting date: 12,500 stock options vest.
08/07/2034Expiration date: Stock options expire.

Keywords

stock options, Form 4, INBP, Integrated BioPharma, director, William Milmoe, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.